Other languages Hercules Capital, Inc.

Equities

HTGC

US4270965084

Real-time Estimate Cboe BZX Other stock markets 02:47:33 2024-05-28 pm EDT			5-day change	1st Jan Change
19.34 ^USD	-0.36%		-1.48%	+16.08%

May. 17	UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating	MT
May. 15	Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	May. 09
Verona Pharma Signs Financing Agreements for Up to $650 Million	May. 09
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	Apr. 30
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	Apr. 30
Bluebird bio to Restate Financial Statements; Shares Fall	Mar. 26
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	Mar. 18
Sector Update: Health Care	Mar. 18
Bluebird bio Secures $175 Million Term Loan Facility	Mar. 18
Hercules Capital Posts Increased Q4 Net, Total Investment Income	Feb. 15
Hercules Capital, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15
Hercules Capital, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15
Hercules Capital, Inc. Declares Cash Distribution for the Fourth Quarter 2023, Dividend Payable on March 6, 2024	Feb. 13
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 Per Share, Payment on March 6, 2024	Feb. 13
Hercules Capital's Q3 Net Investment Income Rises	Nov. 02
Hercules Capital, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Hercules Capital, Inc. Declares Total Cash Distribution the Third Quarter 2023, Payable on November 22, 2023	23-10-31
Hercules Capital Appoints Nikos Theodosopoulos an Independent Member of its Board of Directors and to Serve on Audit Committee	23-09-25
Sector Update: Financial Stocks Advancing Late Wednesday Afternoon	23-08-30
Sector Update: Financial	23-08-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hercules Capital, Inc.

Equities

HTGC

US4270965084

Other languages

Filters